Experiences and Implications of Healthy Weight Management Policies in Japan, South Korea, and Singapore—Based on the ICCC Framework

Corresponding author: GUO Wudong, guowudong@hotmail.com

DOI: 10.12201/bmr.202508.00038

•  

  Abstract: Objective: This study aims to analyze the weight management policy practices in Japan, South Korea, and Singapore to provide international references for improving Chinas weight health management and metabolic disease prevention system. Methods: Based on the Innovative Care for Chronic Conditions Framework (ICCC), we conducted a literature review and policy analysis methods of domestic and international policies and publications on weight management, systematically analyzing and summarizing relevant strategies and practices to extract key insights. Results: All three countries have established a multi-level collaborative governance system: at the macro level, they built institutional foundations through legislation, cross-sectoral collaboration, and diversified financing; at the meso level, they enhanced management efficiency via comprehensive medical services, multidisciplinary coordination, and smart information systems, while community-level initiatives fostered supportive environments through health education and environmental modifications; at the micro level, they emphasized personalized interventions and family involvement to strengthen self-management capabilities. Conclusion: China can learn from these neighboring countries experiences to develop a multi-tiered prevention system, strengthen primary care capacity, improve medical security mechanisms, and facilitate a shift from disease treatment to health management, ultimately constructing a weight management solution with Chinese characteristics.

  Key words: Innovative Care for Chronic Conditions Framework；Weight management; Obesity； Health policy；International experience; 

  Submit time: 18 August 2025

  Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
• html

• 图表

• Han Xinru, Zeng Kangni, Tan Jialong, Wang Jian. Lessons and Enlightments from International Experience of Health Insurance Drug Renewal Policy. 2024. doi: 10.12201/bmr.202407.00031

  HU Hongwei, wanghogbo. The Bottom Line of Medical Security in Singapore from the perspective of Policy Network Governance: institutional framework and experience enlightenment. 2023. doi: 10.12201/bmr.202303.00031

  Deng Ziru, Wang Wei, Fu Chaowei, Yan Fei. International Experience and Implications of Antimicrobials Management Strategies from the One Health Perspective. 2021. doi: 10.12201/bmr.202105.00011

  Wang Hufeng, Zhao Yang. Research trends of chronic diseases in China in the past 6 years before and after the implementation of Healthy China Strategy: Transition from treatment to management. 2023. doi: 10.12201/bmr.202306.00003

  Hu hongwei, Xiang Chuan, Chen yilin. Functional Governance of Pharmacy in Chronic Disease Management System: Theoretical Framework and Path Explanation. 2025. doi: 10.12201/bmr.202502.00053

  xiang cong, gao xiaolian, xiong qianfen, Wang heqing, luo yanling, zhu xinhong, Tao junxiu. Research on characteristics of chronic disease health management informatization based on content analysis. 2024. doi: 10.12201/bmr.202408.00058

  wangru, FENG Jun, JIANG Lu-yi. Domestic and International Experience and Implications of the Development and Utilization of Health Data. 2025. doi: 10.12201/bmr.202511.00041

  Tang Rong, Zhang Huadong, Ding Xianbin, Xia Yuyi, Jiang Ling. The Construction and Practical Application of Regional Chronic Disease Surveillance Management Information Platform Based on Medical Big Data. 2025. doi: 10.12201/bmr.202506.00071

  WANG Hongbo, GONG Xi, ZHANG Su. Strategic Purchase of Health Insurance from the Perspective of Strategic Management in Public Sectors: An Interpretive Framework and Its Chinese Implications. 2024. doi: 10.12201/bmr.202407.00013

  YAN Jian-zhou, LI Da-shuang, Ding Wenjing, SHAO Rong. Comparative study of promoted generic substitution policies in China, USA and Japan based on full cycle management. 2023. doi: 10.12201/bmr.202305.00004

• ID	Submit time	Number	Download
  1	2025-07-08	10.12201/bmr.202508.00038V1	Download

• Public  Anonymous  To author only Submit Comments